3 Potential “Game-Changer” Biotech Stocks With Triple-Digit Upside Potential

2020-05-08 20_58_20-Unrecognizable chemist taking liquid with pipette from test tube in modern labor“Veteran players of the stock picking game know that biotechs are capable of delivering a win at what feels like the drop of a hat,” notes the author of today’s article, who proceeds to highlight three biotech stocks, identified by investment firm Wedbush, with the potential to be game-changers. For these three Buy-rated biotech stocks with triple-digit upside potential, CLICK HERE.

Read More

3 Compelling Picks From “The Ultimate Risk/Reward Plays”

2020-04-19 20_42_02-Blue and Yellow Board Game · Free Stock Photo“With some investors now looking to take on a bit more risk, they are turning to the ultimate risk/reward plays: biotech stocks,” notes the author of today’s article. One of the few major catalysts for biotech stocks is regulatory approval – and the author highlights “three compelling biotech stocks with upcoming Prescription Drug User Fee Act (PDUFA) dates, the deadline by which the FDA must decide to approve or reject a new application.” For these three biotech stocks with “Strong Buy” analyst ratings and significant upside potential – including one firm at the forefront of women’s reproductive health – CLICK HERE.

Read More

How To Earn Better-Than-Average Returns In The Post-Coronavirus Economy

2020-04-16 21_23_35-WindowIf you want to earn just “average” gains in the post-coronavirus economy, invest in broad index funds. But if you want better-than-average returns, stock and non-broad-based ETF picking will be the way to go, argues the author of today’s article. Just what are the many major shifts – from privacy rights to education to biotechnology – that the economy will undergo as a result of the coronavirus pandemic, and which stocks and ETFs will benefit? CLICK HERE.

Read More